Back to all people

Frank Bretz

Novartis Pharma AG

2 appearances in the program

Sessions & presentations

Global Impact of the ICH E9(R1) Addendum - 5-Year Anniversary for the Trial Estimand Framework

Invited Panel Session · Tue, Aug 6 , 2:00 PM

Chair

Practical Considerations for Bayesian and Frequentist Adaptive Clinical Trials

Professional Development Course/CE · Sun, Aug 4 , 8:30 AM

Participant

↑